story of the week
A Transglutaminase 2 Inhibitor for Celiac Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease
N. Engl. J. Med 2021 Jul 01;385(1)35-45, D Schuppan, M Mäki, KEA Lundin, J Isola, T Friesing-Sosnik, J Taavela, A Popp, J Koskenpato, J Langhorst, Ø Hovde, ML Lähdeaho, S Fusco, M Schumann, HP Török, J Kupcinskas, Y Zopf, AW Lohse, M Scheinin, K Kull, L Biedermann, V Byrnes, A Stallmach, J Jahnsen, J Zeitz, R Mohrbacher, R GreinwaldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.